ICM
GNMX

Ionic Capital Management’s Aevi Genomic Medicine Inc GNMX Stock Holding History

Ionic Capital Management’s Portfolio GNMX Stock Details GNMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-7,500
Closed -$60K – 345
2015
Q1 		$60K Buy
+7,500
New +$56.6K ﹤0.01% 259

Other funds holding GNMX

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Ionic Capital Management's GNMX Position: Q2 2015 in Review

Ionic Capital Management sold out of Aevi Genomic Medicine Inc (GNMX) in Q2 2015, closing a stake of 7,500 shares — an estimated $60K sold.

Ionic Capital Management first reported a position in GNMX in Q1 2015 and held it in 1 quarter. The position peaked at $60K in Q1 2015. 54 funds tracked by Wall St. Rank hold GNMX as of Q2 2015.

  • Ionic Capital Management reported no remaining Aevi Genomic Medicine Inc position as of Q2 2015 after selling out during the quarter.
  • Ionic Capital Management sold 7,500 Aevi Genomic Medicine Inc shares in Q2 2015, an estimated $60K.
  • Ionic Capital Management first reported a position in Aevi Genomic Medicine Inc in Q1 2015 and held it in 1 quarter.
  • Ionic Capital Management's Aevi Genomic Medicine Inc position peaked at $60K in Q1 2015.
  • 54 funds tracked by Wall St. Rank held Aevi Genomic Medicine Inc as of Q2 2015.

Based on Ionic Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.